Literature DB >> 16267501

Genetics of the Lp(a)/apo(a) system in an autochthonous Black African population from the Gabon.

Konrad Schmidt1, Hans Georg Kraft, Walther Parson, Gerd Utermann.   

Abstract

Plasma lipoprotein(a) (Lp(a)) is a quantitative trait associated with atherothrombotic disease in European and Asian populations. Lp(a) concentrations vary widely within and between populations, with Africans exhibiting on average two- to threefold higher Lp(a) levels and a different distribution compared to Europeans. The apo(a) gene locus on chromosome 6q26-27 (LPA, MIM 152200) has been identified as the major quantitative trait locus (QTL) for Lp(a) concentrations in Europeans and populations of African descent (North American and South African Blacks) but data on autochthonous Black Africans are lacking.Here, we have analysed Lp(a) plasma concentrations, apo(a) isoforms in plasma and four polymorphisms in the LPA gene in 31 African families with 54 children from Gabon. Weighted midparent-offspring regression estimated a heritability h2=0.76. The correlation of Lp(a) levels associated with LPA alleles identical by descent (IBD) resulted in a heritability estimate of 0.801. Our data demonstrate that Lp(a) concentrations are highly heritable in a Central African population without admixture and high Lp(a) (median 43 mg/dl). LPA is the major QTL, explaining most or all of the heritability of Lp(a) in this population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16267501     DOI: 10.1038/sj.ejhg.5201512

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  15 in total

1.  Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.

Authors:  Carole Ober; Alex S Nord; Emma E Thompson; Lin Pan; Zheng Tan; Darren Cusanovich; Ying Sun; Raluca Nicolae; Celina Edelstein; Daniel H Schneider; Christine Billstrand; Ditta Pfaffinger; Natasha Phillips; Rebecca L Anderson; Binu Philips; Ramakrishnan Rajagopalan; Thomas S Hatsukami; Mark J Rieder; Patrick J Heagerty; Deborah A Nickerson; Mark Abney; Santica Marcovina; Gail P Jarvik; Angelo M Scanu; Dan L Nicolae
Journal:  J Lipid Res       Date:  2009-01-05       Impact factor: 5.922

Review 2.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

3.  Heritability of apolipoprotein (a) traits in two-generational African-American and Caucasian families.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Kyoungmi Kim; Lars Berglund
Journal:  J Lipid Res       Date:  2019-07-18       Impact factor: 5.922

4.  LPA and PLG sequence variation and kringle IV-2 copy number in two populations.

Authors:  Dana C Crawford; Ze Peng; Jan-Fang Cheng; Dario Boffelli; Magdalena Ahearn; Dan Nguyen; Tristan Shaffer; Qian Yi; Robert J Livingston; Mark J Rieder; Deborah A Nickerson
Journal:  Hum Hered       Date:  2008-07-09       Impact factor: 0.444

Review 5.  The chitinase and chitinase-like proteins: a review of genetic and functional studies in asthma and immune-mediated diseases.

Authors:  Carole Ober; Geoffrey L Chupp
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-10

6.  Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey.

Authors:  Logan Dumitrescu; Kimberly Glenn; Kristin Brown-Gentry; Cynthia Shephard; Michelle Wong; Mark J Rieder; Joshua D Smith; Deborah A Nickerson; Dana C Crawford
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

7.  Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations.

Authors:  Asma Noureen; Friedrich Fresser; Gerd Utermann; Konrad Schmidt
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

Review 8.  Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases.

Authors:  Florian Kronenberg
Journal:  Cardiovasc Drugs Ther       Date:  2016-02       Impact factor: 3.727

9.  Deep coverage whole genome sequences and plasma lipoprotein(a) in individuals of European and African ancestries.

Authors:  Seyedeh M Zekavat; Sanni Ruotsalainen; Robert E Handsaker; Maris Alver; Jonathan Bloom; Timothy Poterba; Cotton Seed; Jason Ernst; Mark Chaffin; Jesse Engreitz; Gina M Peloso; Ani Manichaikul; Chaojie Yang; Kathleen A Ryan; Mao Fu; W Craig Johnson; Michael Tsai; Matthew Budoff; Ramachandran S Vasan; L Adrienne Cupples; Jerome I Rotter; Stephen S Rich; Wendy Post; Braxton D Mitchell; Adolfo Correa; Andres Metspalu; James G Wilson; Veikko Salomaa; Manolis Kellis; Mark J Daly; Benjamin M Neale; Steven McCarroll; Ida Surakka; Tonu Esko; Andrea Ganna; Samuli Ripatti; Sekar Kathiresan; Pradeep Natarajan
Journal:  Nat Commun       Date:  2018-07-04       Impact factor: 14.919

10.  Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.

Authors:  Stephen Zewinger; Marcus E Kleber; Vinicius Tragante; Raymond O McCubrey; Amand F Schmidt; Kenan Direk; Ulrich Laufs; Christian Werner; Wolfgang Koenig; Dietrich Rothenbacher; Ute Mons; Lutz P Breitling; Herrmann Brenner; Richard T Jennings; Ioannis Petrakis; Sarah Triem; Mira Klug; Alexandra Filips; Stefan Blankenberg; Christoph Waldeyer; Christoph Sinning; Renate B Schnabel; Karl J Lackner; Efthymia Vlachopoulou; Ottar Nygård; Gard Frodahl Tveitevåg Svingen; Eva Ringdal Pedersen; Grethe S Tell; Juha Sinisalo; Markku S Nieminen; Reijo Laaksonen; Stella Trompet; Roelof A J Smit; Naveed Sattar; J Wouter Jukema; Heinrich V Groesdonk; Graciela Delgado; Tatjana Stojakovic; Anna P Pilbrow; Vicky A Cameron; A Mark Richards; Robert N Doughty; Yan Gong; Rhonda Cooper-DeHoff; Julie Johnson; Markus Scholz; Frank Beutner; Joachim Thiery; J Gustav Smith; Ragnar O Vilmundarson; Ruth McPherson; Alexandre F R Stewart; Sharon Cresci; Petra A Lenzini; John A Spertus; Oliviero Olivieri; Domenico Girelli; Nicola I Martinelli; Andreas Leiherer; Christoph H Saely; Heinz Drexel; Axel Mündlein; Peter S Braund; Christopher P Nelson; Nilesh J Samani; Daniel Kofink; Imo E Hoefer; Gerard Pasterkamp; Arshed A Quyyumi; Yi-An Ko; Jaana A Hartiala; Hooman Allayee; W H Wilson Tang; Stanley L Hazen; Niclas Eriksson; Claes Held; Emil Hagström; Lars Wallentin; Axel Åkerblom; Agneta Siegbahn; Igor Karp; Christopher Labos; Louise Pilote; James C Engert; James M Brophy; George Thanassoulis; Peter Bogaty; Wojciech Szczeklik; Marcin Kaczor; Marek Sanak; Salim S Virani; Christie M Ballantyne; Vei-Vei Lee; Eric Boerwinkle; Michael V Holmes; Benjamin D Horne; Aroon Hingorani; Folkert W Asselbergs; Riyaz S Patel; Bernhard K Krämer; Hubert Scharnagl; Danilo Fliser; Winfried März; Thimoteus Speer
Journal:  Lancet Diabetes Endocrinol       Date:  2017-05-26       Impact factor: 32.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.